Dr. Boyd is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 main
Yakima, WA 98908Phone+1 541-683-5001Fax+1 541-683-1422
Education & Training
- University of Iowa Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 1982 - 1985
- University of Iowa (Des Moines)Residency, Internal Medicine, 1979 - 1982
- University of Texas Southwestern Medical SchoolClass of 1979
Certifications & Licensure
- OR State Medical License 2016 - 2025
- WA State Medical License 1985 - 2025
- IA State Medical License 1979 - 1991
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 220 citationsBiallelic Inactivation of BRCA2 in Platinum-sensitive Metastatic Castration-resistant Prostate Cancer.Heather H. Cheng, Colin C. Pritchard, Thomas Boyd, Peter S. Nelson, Bruce Montgomery
European Urology. 2016-06-01 - 50 citationsPhase II evaluation of LY2603618, a first-generation CHK1 inhibitor, in combination with pemetrexed in patients with advanced or metastatic non-small cell lung cancerGiorgio V. Scagliotti, Jin Hyoung Kang, David J. Smith, Richard K. Rosenberg, Keunchil Park
Investigational New Drugs. 2016-06-27 - 91 citationsSotatercept with long-term extension for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes: a phase 2, dose-ranging trialRami S. Komrokji, Guillermo Garcia-Manero, Lionel Ades, Thomas Prebet, David P. Steensma
The Lancet. Haematology. 2018-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: